On February 5, 2026, Shenzhen Lifetech Scientific Co., Ltd. (Stock Code: 688712.SH) officially commenced trading on the Science and Technology Innovation Board (also known as the STAR Market) of the Shanghai Stock Exchange. This milestone marks it as the first medical device company to achieve a successful listing on the STAR Market since 2024. Lifetech Scientific is dedicated to the research and development, production, and marketing of cutting-edge medical devices tailored for precise diagnosis and treatment of cardiovascular diseases. Among its flagship products, the Intravascular Ultrasound (IVUS) Diagnostic System and the Fractional Flow Reserve (FFR) Measurement System stand out as pioneering innovations in China. These products have broken the long-standing monopoly previously held by overseas medical device giants.
